Liberator reports increases across the board
STUART, Fla. – Liberator Medical’s net sales were $18.6 million in its fiscal first quarter ended Dec. 31, 2013, up 6.2% over the same period in 2012, the company announced Feb. 13.
Net income was $2.12 million, a 56.8% increase; gross profits were $11.7 million, a 7.1% increase; and operating income was $3.5 million, a 55% increase.
Liberator Medical, which began trading on the New York Stock Exchange in November, credits its focus on maximizing reorder rates from recurring customers and its direct response advertising campaign for the positive results.
“We will continue to manage the levels of our direct response advertising spend, implement process improvements and explore potential acquisition targets to grow our business and increase operating margins during fiscal year 2014,” stated Mark Libratore, president and CEO, in the release.